2.045 USD
-0.23 (-9.91%)
2.04 USD
0 (-0.24%)
Taking everything into account, ATLN scores 2 out of 10 in our fundamental rating. ATLN was compared to 58 industry peers in the Life Sciences Tools & Services industry. ATLN may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ATLN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ATLN had negative earnings in the past year.
ATLN had a positive operating cash flow in the past year.
In the past 5 years ATLN always reported negative net income.
In the past 5 years ATLN always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -91.01%, ATLN is doing worse than 91.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -91.01% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ATLN has a Gross Margin of 10.79%. This is amonst the worse of the industry: ATLN underperforms 86.21% of its industry peers.
ATLN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ATLN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.8% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
2. Health
2.1 Basic Checks
ATLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATLN has more shares outstanding
ATLN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATLN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.90 indicates that ATLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ATLN has a Altman-Z score of 1.90. This is comparable to the rest of the industry: ATLN outperforms 44.83% of its industry peers.
ATLN has a debt to FCF ratio of 23.49. This is a negative value and a sign of low solvency as ATLN would need 23.49 years to pay back of all of its debts.
ATLN has a Debt to FCF ratio (23.49) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 23.49 | ||
| Altman-Z | 1.9 |
ROIC/WACCN/A
WACC12.2%
2.3 Liquidity
A Current Ratio of 1.31 indicates that ATLN should not have too much problems paying its short term obligations.
ATLN has a Current ratio of 1.31. This is amonst the worse of the industry: ATLN underperforms 82.76% of its industry peers.
A Quick Ratio of 1.31 indicates that ATLN should not have too much problems paying its short term obligations.
ATLN's Quick ratio of 1.31 is on the low side compared to the rest of the industry. ATLN is outperformed by 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 77.52% over the past year.
The Revenue has grown by 115.85% in the past year. This is a very strong growth!
The Revenue has been growing by 284.02% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)77.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.97%
Revenue 1Y (TTM)115.85%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%-1.66%
3.2 Future
Based on estimates for the next years, ATLN will show a small growth in Earnings Per Share. The EPS will grow by 3.08% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-12.5%
EPS Next 2Y3.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ATLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ATLN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ATLN is cheaper than 67.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.3 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.08%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ATLN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.045
-0.23 (-9.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners1.96%
Inst Owner Change53.56%
Ins Owners35.46%
Ins Owner Change-2.49%
Market Cap119.69M
Revenue(TTM)443.06M
Net Income(TTM)-97.16M
Analysts85.71
Price Target6.12 (199.27%)
Short Float %3.07%
Short Ratio4.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5931.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.27 | ||
| P/FCF | 37.3 | ||
| P/OCF | 36.58 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.96
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)0.05
FCFY2.68%
OCF(TTM)0.06
OCFY2.73%
SpS7.57
BVpS-0.32
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -91.01% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.8% | ||
| FCFM | 0.72% |
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
F-Score5
Asset Turnover4.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 23.49 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.28% | ||
| Cap/Sales | 0.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 1.9 |
F-Score5
WACC12.2%
ROIC/WACCN/A
Cap/Depr(3y)29.06%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.97%
EPS Next Y-12.5%
EPS Next 2Y3.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)115.85%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%-1.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-154.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y171.39%
OCF growth 3YN/A
OCF growth 5YN/A
ATLANTIC INTERNATIONAL CORP / ATLN FAQ
What is the ChartMill fundamental rating of ATLANTIC INTERNATIONAL CORP (ATLN) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ATLN.
What is the valuation status of ATLANTIC INTERNATIONAL CORP (ATLN) stock?
ChartMill assigns a valuation rating of 1 / 10 to ATLANTIC INTERNATIONAL CORP (ATLN). This can be considered as Overvalued.
Can you provide the profitability details for ATLANTIC INTERNATIONAL CORP?
ATLANTIC INTERNATIONAL CORP (ATLN) has a profitability rating of 0 / 10.
What is the expected EPS growth for ATLANTIC INTERNATIONAL CORP (ATLN) stock?
The Earnings per Share (EPS) of ATLANTIC INTERNATIONAL CORP (ATLN) is expected to decline by -12.5% in the next year.